BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37560749)

  • 1. Reducing Dietary Acid With Fruit and Vegetables Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD): A Clinical Research Protocol.
    Mollard R; Cachero K; Luhovyy B; Martin H; Moisiuk S; Mahboobi S; Balshaw R; Collister D; Cahill L; Tennankore KK; Tangri N; MacKay D
    Can J Kidney Health Dis; 2023; 10():20543581231190180. PubMed ID: 37560749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
    Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
    Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The "Nutritional Light Signal" of the Renal Acid Load.
    Di Iorio BR; Di Micco L; Marzocco S; De Simone E; De Blasio A; Sirico ML; Nardone L;
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
    Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ
    Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary potassium liberalization with fruit and vegetables versus potassium restriction in people with chronic kidney disease (DK-Lib CKD): a clinical trial protocol.
    Iman Y; Balshaw R; Alexiuk M; Hingwala J; Cahill L; Mollard R; Tangri N; Mackay D
    BMC Nephrol; 2023 Oct; 24(1):301. PubMed ID: 37833679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
    Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease.
    Siener R
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29677110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reno-protective effects of oral alkalizing agents in chronic kidney disease with aciduria: protocol for a randomized cohort study.
    Abe M; Akaishi T; Shoji M; Yamaguchi T; Miki T; Satoh F; Takayama S; Yamasaki S; Kawaguchi K; Sato H; Ishii T; Ito S;
    BMC Nephrol; 2020 Apr; 21(1):144. PubMed ID: 32321450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
    Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
    Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease.
    Scialla JJ; Appel LJ; Astor BC; Miller ER; Beddhu S; Woodward M; Parekh RS; Anderson CA
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1526-32. PubMed ID: 21700817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the Metabolic Acidosis of Chronic Kidney Disease.
    Goraya N; Wesson DE
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):298-304. PubMed ID: 29031356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaline Diet and Metabolic Acidosis: Practical Approaches to the Nutritional Management of Chronic Kidney Disease.
    Rodrigues Neto Angéloco L; Arces de Souza GC; Almeida Romão E; Garcia Chiarello P
    J Ren Nutr; 2018 May; 28(3):215-220. PubMed ID: 29221627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
    Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
    J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Chronic Kidney Disease-Related Metabolic Acidosis With Fruits and Vegetables Compared to NaHCO
    Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
    J Ren Nutr; 2021 May; 31(3):239-247. PubMed ID: 32952009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.